首页 文献索引 SCI期刊 AI助手
首页 正文

Correction: Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy

{{output}}